Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team

被引:100
作者
Bleiziffer, Sabine [1 ]
Ruge, Hendrik [1 ]
Mazzitelli, Domenico [1 ]
Schreiber, Christian [1 ]
Hutter, Andrea [1 ]
Laborde, Jean-Claude [1 ]
Bauernschmitt, Robert [1 ]
Lange, Ruediger [1 ]
机构
[1] German Heart Ctr Munich, Cardiovasc Surg Clin, D-80636 Munich, Germany
关键词
Valves; Aortic stenosis; Minimally invasive; Interventional; COREVALVE REVALVING(TM) SYSTEM; HIGH-RISK PATIENTS; SURGERY; OCTOGENARIANS; REPLACEMENT; PROSTHESIS; STENOSIS; OUTCOMES; CARDIOLOGY; STATEMENT;
D O I
10.1016/j.ejcts.2008.12.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Transcatheter aortic valve implantation has been performed by several groups, most of them either specializing on the transapical (surgeons) or the percutaneous femoral transarterial approach (cardiologists). We achieved both transapical and percutaneous transcatheter valve implantation by a surgical team in a hybrid suite. Methods: Since June 2007, 137 patients (n = 78 female, mean age 81 7 years) underwent transcatheter aortic valve implantation (n = 109 transfemoral, n = 3 via subclavian artery, n = 2 directly through ascending aorta, n = 23 transapical) with the CoreValve (n = 114) or the Edwards Sapien (n = 23) prosthesis. Results: Thirty-day mortality was 12.4% in this patient cohort. One hundred and eight patients (78.8%) are alive at a mean follow-up of 97 82 days. Pacemaker implantation due to postoperative AV block was performed in 27 patients (19.7%), and 7 patients (5.1%) sustained neurological events. Patients improved in NYHA class (from 3.1 +/- 0.3 to 1.9 +/- 0.5, p < 0.001) and in self-assessed health state (from 55 +/- 17% to 68 +/- 16%, p < 0.001) at one-month follow-up. Echocardiographic assessment revealed excellent hemodynamic function of the prostheses with a mean aortic gradient (MAG) of 11.9 +/- 4.4 mmHg and an effective orifice area (EOA) of 1.6 +/- 0.4 cm(2) at discharge and a MAG of 11.0 +/- 4.2 mmHg and an EOA of 1.6 +/- 0.3 cm(2) at six months FU. Conclusions: Transcatheter aortic valve implantation has become an alternative technique for the treatment of aortic stenosis with reasonable short- and midterm results at our institution. With the opportunity to treat aortic stenosis by conventional surgical valve replacement and transapical and percutaneous transcatheter procedures, the technique of lowest risk for the individual patient can be chosen and performed by one team. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:615 / 621
页数:7
相关论文
共 21 条
  • [1] Valvular surgery in octogenarians: operative risks factors, evaluation of Euroscore and long term results
    Collart, F
    Feier, H
    Kerbaul, F
    Mouly-Bandini, A
    Riberi, A
    Mesana, TG
    Metras, D
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 27 (02) : 276 - 280
  • [2] Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis - First human case description
    Cribier, A
    Eltchaninoff, H
    Bash, A
    Borenstein, N
    Tron, C
    Bauer, F
    Derumeaux, G
    Anselme, F
    Laborde, F
    Leon, MB
    [J]. CIRCULATION, 2002, 106 (24) : 3006 - 3008
  • [3] Eltchaninoff Helene, 2003, J Interv Cardiol, V16, P515, DOI 10.1046/j.1540-8183.2003.01051.x
  • [4] High-risk aortic valve replacement: Are the outcomes as bad as predicted?
    Grossi, Eugene A.
    Schwartz, Charles F.
    Yu, Pey-Jen
    Jorde, Ulrich P.
    Crooke, Gregory A.
    Grau, Juan B.
    Ribakove, Greg H.
    Baumann, F. Gregory
    Ursumanno, Patricia
    Culliford, Alfred T.
    Colvin, Stephen B.
    Galloway, Aubrey C.
    [J]. ANNALS OF THORACIC SURGERY, 2008, 85 (01) : 102 - 107
  • [5] Percutaneous aortic valve replacement for severe aortic stenosis in high-rick patients using the second- and current third-generation self-expanding CoreValve prosthesis - Device success and 30-day clinical outcome
    Grube, Eberhard
    Schuler, Gerhard
    Buellesfeld, Lutz
    Gerckens, Ulrich
    Linke, Axel
    Wenaweser, Peter
    Sauren, Barthel
    Mohr, Friedrich-Wilhelm
    Walther, Thomas
    Zickmann, Bernfried
    Iversen, Stein
    Felderhoff, Thomas
    Cartier, Raymond
    Bonan, Raoul
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (01) : 69 - 76
  • [6] Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease - The Siegburg First-in-Man Study
    Grube, Eberhard
    Laborde, Jean C.
    Gerckens, Ulrich
    Felderhoff, Thomas
    Sauren, Barthel
    Buellesfeld, Lutz
    Mueller, Ralf
    Menichelli, Maurizio
    Schmidt, Thomas
    Zickmann, Bernfried
    Iversen, Stein
    Stone, Gregg W.
    [J]. CIRCULATION, 2006, 114 (15) : 1616 - 1624
  • [7] Aortic valve surgery in octogenarians: predictive factors for operative and long-term results
    Kolh, Philippe
    Kerzmann, Arnaud
    Honore, Charles
    Comte, Laetitia
    Limet, Raymond
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 31 (04) : 600 - 605
  • [8] First successful transapical aortic valve implantation with the Corevalve Revalving™ System:: A case report
    Lange, Ruediger
    Schreiber, Christian
    Goetz, Wolfgang
    Hettich, Ina
    Will, Albrecht
    Libera, Paul
    laborde, Jean-Claude
    Bauernschmitt, Robert
    [J]. HEART SURGERY FORUM, 2007, 10 (06) : E478 - E479
  • [9] Transapical transcatheter aortic valve implantation in humans - Initial clinical experience
    Lichtenstein, Samuel V.
    Cheung, Anson
    Ye, Jian
    Thompson, Christopher R.
    Carere, Ronald G.
    Pasupati, Sanjeevan
    Webb, John G.
    [J]. CIRCULATION, 2006, 114 (06) : 591 - 596
  • [10] RICHARDS KL, 1991, CIRCULATION, V84, pI182